OXB — Oxford BioMedica Share News
0.000.00%
Last trade - 00:00- £616.15m
- £699.51m
- £168.74m
PDMR Dealing
Grant of Award
PDMR Dealing
PDMR Dealing
PDMR Dealing
UK's Oxford Biomedica falls as H1 operating loss widens
UK Stocks-Factors to watch on September 22 (updated)
UK's Oxford BioMedica H1 revenue rises on increased manufacturing
Brief: Oxford BioMedica H1 Revenue GBP 79.8 Million
Interim Results
Holding(s) in Company
UK Stocks-Factors to watch on September 22
Holding(s) in Company
Holding(s) in Company
Europe Research Roundup: AstraZeneca, GSK, Kingspan Group
Holding(s) in Company
Holding(s) in Company
Oxford BioMedica slides as Novartis, Bristol-Myers Squibb pause CAR-T autoimmune trials
Admission to Trading Application